Plain-English translation of NCT06099795 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new portable device called eBAM-CoV that detects COVID-19 by analyzing your breath. Unlike the standard nasal swab test, this device is non-invasive and gives results quickly, showing both whether you have the virus and how much virus is present. The study will compare how well this breath test matches the results of the standard COVID test.
The current COVID test using nasal swabs can be uncomfortable, sometimes gives inconsistent results, and requires multiple steps to process. This trial exists to see if the new breath test can be a simpler, faster, and more reliable alternative that could help detect COVID-19 more easily.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will provide a breath sample using the new eBAM-CoV device and also complete the standard nasal swab COVID test. The breath test is quick and painless—you simply breathe into the portable device. Researchers will then compare the results from both tests to see how accurately the breath test detects COVID-19.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Collaborators
University of Nimes, brains' laboratory sas, FRANCE
Enrollment target
~250 participants
Started
January 2025
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Valérie COMPAN, PhD
Centre Hospitalier Universitaire de Nīmes
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.